Validity of at-home rapid antigen lateral flow assay and artificial intelligence read to detect SARS-CoV-2.

Journal: Diagnostic microbiology and infectious disease
PMID: 36070629

Abstract

BACKGROUND: The gold standard for COVID-19 diagnosis-reverse-transcriptase polymerase chain reaction (RT-PCR)- is expensive and often slow to yield results whereas lateral flow tests can lack sensitivity.

Authors

  • Shannon Martin
    Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA.
  • Michael A Kohn
    Stanford University, Department of Emergency Medicine UCSF, Department of Epidemiology and Biostatistics, Stanford, CA, United States of America. Electronic address: makohn@stanford.edu.
  • Jenna Bollyky
    Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
  • Julie Parsonnet
    Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: parsonnt@stanford.edu.

Keywords

External Resources

Popular Topics
Recent Journals